LifeApps Brands Inc. Confirms Letter of Intent with Medical
Device Company FemCap Inc.
SAN DIEGO, CA -- June, 8 2016 -- InvestorsHub NewsWire
-- LifeApps Brands Inc. (OTC: LFAP) (LifeApps), an emerging
growth company, and designer of m-health and wellness applications
has entered into an agreement with medical device company FemCap
Inc. LifeApps previously released
Letter of Intent with Femcap May, 26 2016 in conjuction with an
8-K.
FemCap Inc. provides innovative FDA approved contraceptive and
feminine hygiene medical device products designed for todays
healthy lifestyles of engaged women.
Under the agreement LifeApps has a 90-day exclusive right to
purchase FemCaps operating assets used to market and sell FemCap
and FemmyCycle feminine hygiene products. The LOI also includes
utilizing the expertise and experience of FemCap founder Dr. Alfred
Shihata. Dr. Shihata brings to the team a wealth of experience in
research and development of contraceptive and feminine hygiene
medical devices as well as being affiliated with Scripps
Institutions of Medicine and Science in San Diego, CA and holding 6
U.S. Patents and numerous international patents, including FemCap
and FemmyCycle.
FemCap products include the FemCap contraceptive device and the
FemmyCycle menstrual cup. These feminine contraceptive and hygiene
products are clinically tested and FDA approved. The products have
health and wellness benefits over traditionally used contraceptive
and feminine hygiene products. Additionally, they are more
environmentally friendly (reusable), safe, and easy to use while
providing cost savings over traditional products in their markets.
In 2015 over 1200 clinicians and clinics were on FemCaps customer
list.
FemCap products have both U.S. and international distribution.
FemCap requires a prescription in the United States and is
currently distributed via Medical Practices and is available
without prescription internationally. FemmyCycle is a consumer
product and is currently distributed online via Amazon.com, FemCaps
website and select retailers. We see great growth potential for
both products by expanding the awareness of the health benefits of
these innovative products through aggressive marketing and expanded
distribution options. FemCap has already seen a 41% increase in
sales in the last two years with a gross profit margin of 66%.
LifeApps is incredibly excited to enter into this agreement with
Dr. Shihata and FemCap, states Robert Gayman, CEO of LifeApps. Dr.
Shihata has created a pair of truly innovative contraceptive and
feminine hygiene products that women love. LifeApps is eager to
expand the marketing efforts behind these incredible products and
make them more accessible to women globally. We strongly believe
that the growth potential for these products is massive and
LifeApps has the experience raising brand awareness to make FemCap
and FemmyCycle the first choice in feminine contraceptive and
hygiene products for women around the world.
About LifeApps Brands Inc.
LifeApps is a leading, authorized developer, publisher and
licensee for Apple iOS iPhone, iPod Touch, and iPad and Android
tablets on Google Play and Kindle Fire and Androids via Amazon
Mobile Marketplace. LifeApps Brands is actively seeking strategic
partnerships and acquisitions for products across a wide range of
markets including financial, entertainment and gaming.
For more information about LifeApps, please visit: http://www.lifeappsbrands.com
Forward-Looking Statements
This release contains "forward-looking statements" as that term
is used under the federal securities laws. Such statements may be
identified by the use of words such as "anticipate," "believe,"
"expect," "future," "may," "will," "would," "should," "plan,"
"projected," "intend," and similar expressions. These
forward-looking statements including statements about the agreement
with FemCap Inc. are subject to various risks and uncertainties
that could cause LifeApps actual results to differ materially from
those currently anticipated, including risks and uncertainties
relating to the Company's business, product development, marketing
and distribution plans and strategies. These and other factors are
identified and described in more detail in the Company's filings
with the Securities and Exchange Commission (the SEC) including the
Company's annual report on Form 10-K filed with the SEC on April
15, 2015. The Company does not undertake to update these
forward-looking statements.
Company Contact
David S. Dawson
3790 Via De La Valle
Polo Plaza #116 E
Del Mar, CA 92014
info@lifeappsmedia.com
(858) 577-0500